Evotec is a global biotechnology company with over 5,000 professionals across 17 locations in 6 countries. The company operates in drug discovery and preclinical development, working with small molecules, biologics, and biotherapeutics alongside next-generation technology platforms.
The company's work spans the full preclinical pipeline, from initial drug discovery through to manufacturing. Just – Evotec Biologics, a dedicated unit within the company, focuses specifically on designing, developing, and manufacturing biologics with the stated aim of making high-quality therapies more accessible and affordable.
Evotec operates through collaborative partnerships, combining internal scientific capabilities with external collaborations to advance drug development programmes. The company's scale and geographic distribution position it as a significant contract research and development provider to the broader pharmaceutical and biotechnology sectors.
